Ad
INDP - Indaptus Therapeutics Stock Trading
About | Indaptus Therapeutics Inc. (NASDAQ:INDP)
Quote | Indaptus Therapeutics Inc. (NASDAQ:INDP)
| Last: | $2.755 |
|---|---|
| Change Percent: | 2.55% |
| Open: | $2.68 |
| Close: | $2.755 |
| High: | $2.8 |
| Low: | $2.68 |
| Volume: | 5,727 |
| Last Trade Date Time: | 09/29/2023 03:00:00 am |
News | Indaptus Therapeutics Inc. (NASDAQ:INDP)
-
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will present a corporate overview at the LD Micro Main Event XVI. The conference is being held on October 3 – 5, 2023 at the Luxe Sunset...
-
NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (NASDAQ: INDP) announces that Indaptus’ CEO, Jeffrey Meckler will present at Tribe Public’s Webinar Presentation and Q&A Event titled “ Immunotherapy Reimagined." The Event is scheduled to begin ...
Message Board Posts | Indaptus Therapeutics Inc. (NASDAQ:INDP)
| Subject | By | Source | When |
|---|---|---|---|
| $INDP MomentumIts gaining | Surfacetite | investorshub | 05/08/2023 8:37:38 AM |
| $INDP got some short data | DeadCellShadix | investorshub | 05/08/2023 1:32:26 AM |
| Price gaining | Surfacetite | investorshub | 05/07/2023 3:23:16 PM |
| $INDP MomentumIts now last trade up | MonstaGains | investorshub | 05/03/2023 4:25:58 PM |
| The gaining up | MonstaGains | investorshub | 05/01/2023 7:51:29 PM |
Indaptus Therapeutics Inc. Company Name:
INDP Stock Symbol:
NASDAQ Market:
Ad
-
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (NASDAQ:INDP) announced today that Jeffrey A. Meckler, Chief Executive ...
-
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will present a corporate overview at the LD Micro Main Event XVI. The conference is being held on October 3 – 5, 2023 at the Luxe Sunset...
-
NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (NASDAQ:INDP) announces that Indaptus' CEO, Jeffrey Meckler will p...